Suntrust Banks’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-10,585
Closed -$1.06M 1278
2014
Q4
$1.06M Buy
10,585
+1,298
+14% +$101K 0.01% 583
2014
Q3
$615K Sell
9,287
-669
-7% -$43.9K ﹤0.01% 885
2014
Q2
$694K Sell
9,956
-6,438
-39% -$438K ﹤0.01% 862
2014
Q1
$1.2M Buy
16,394
+4,471
+37% +$333K ﹤0.01% 878
2013
Q4
$820K Buy
11,923
+3,008
+34% +$195K ﹤0.01% 1028
2013
Q3
$564K Sell
8,915
-49,614
-85% -$3M ﹤0.01% 1176
2013
Q2
$2.82M Buy
+58,529
New +$2.88M 0.01% 531

Suntrust Banks's CBST Position: Q1 2015 in Review

Suntrust Banks sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 10,585 shares — an estimated $1.06M sold.

Suntrust Banks first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $2.82M in Q2 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Suntrust Banks reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Suntrust Banks sold 10,585 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.06M.
  • Suntrust Banks first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Suntrust Banks's CUBIST PHARMACEUTICALS INC position peaked at $2.82M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Suntrust Banks's 13F filing for Q1 2015, filed 12 May 2015.